The Innovation Spotlight: KeraVet Bio

First published in The Fountain Report on February 2, 2024

Wound treatment is a vital but often complicated and stressful process for pets. KeraVet® Bio wants to improve the outcome and the experience with KeraVet Gel.

With the keratin-based gel, KeraVet Bio’s leaders aim to simplify wound care and, importantly, make the often-used protective cone obsolete.

“We want to provide a clear, simple course of care and replace current standards of care for wounds, which often use multiple products…as well as some type of bandage or E-collar,” said KeraVet Bio Founder and CEO Luke Burnett, PhD. “By reducing the need for the E-collar, which causes stress and anxiety to the pet and to those around them, we can protect the human-animal bond and improve compliance.”

The gel is modeled after KeraStat Gel, an FDA-cleared keratin-based wound care product used by medical specialists. Reformulated for dogs and cats, KeraVet Gel has been developed to manage wounds, surgical and otherwise, by maintaining a moist wound bed, providing a protective barrier and preventing licking. It’s meant to eliminate the need for more than one product to manage wounds, and is priced below, or comparably, to other standards of care, according to the company.

“Our goal is to reduce or even eliminate the need for secondary bandages and e-collars, which will make the wound healing process less traumatic for the pet and the pet parent and will provide the veterinary staff better wound treatment options.” We have clinical data from two randomized controlled studies in both dogs and cats that is in the process of being submitted for publication that we think will be very exciting to the veterinary community,” Burnett said.

Luke Burnett, PhD, KeraVet Bio Founder and CEO and one of his three dogs, Ollie.

He noted that both KeraVet Gel and KeraVet Powder—an accompanying product that the company plans to roll out in the future, along with a cream—have been used on challenging wounds.

In one case study, KeraVet Bio monitored the gel over the course of a month as it was used to manage a venomous bite wound. On the first day of observation, the doctor noted a wound of this severity often leads to amputation. After two weeks of treatment with the gel and powder, doctors determined amputation was no longer necessary but noted grafting likely would be.

After three weeks, grafting was no longer necessary and the wound bed showed positive signs of healing. By day 31, the wound was on course to heal fully without further interventions.

KeraVet Gel is a prescription product and can be purchased by veterinarians through MWI Animal Health or the online marketplace VetCove.

KeraVet Bio is in the process of completing an oversubscribed investment round and hosts a board that includes several notable veterinary industry members.

The Fountain Report is a weekly newsletter published by Antelligence, delivering the latest news, commentary and data from across the animal health sector to veterinary professionals and other key industry players. To learn more, visit Antelligence.com.